Why Recursion Pharmaceuticals (RXRX) Stock Went Down On Thursday?
We recently published a list of 10 Firms Hit Hard in Thursday’s Trading. In this article, we are going to take a look at ...
Recursion Pharmaceuticals’ (RXRX) AI Approach to Drug Discovery Shows Progress
Recursion Pharmaceuticals (RXRX) is a clinical-stage biotechnology company utilizing artificial intelligence to expedite drug ...
Yahoo Finance3d
Recursion Pharmaceuticals, Inc. (RXRX)
03, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio ... of 30,769,230 shares of its Class A common stock at a price to the public of $6.50 per share.
Recursion Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:RXRX)
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) was the target of some unusual options trading on Thursday. Investors acquired 23,699 call options on the company. This is an increase ...
Nasdaq5d
March 28th Options Now Available For Recursion Pharmaceuticals (RXRX)
Investors in Recursion Pharmaceuticals Inc (Symbol: RXRX) saw new options begin trading today, for the March 28th expiration. At Stock Options Channel, our YieldBoost formula has looked up and ...